GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID: 31958178
Publication Date: 2020/01/20

Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.


To evaluate the association between mild acute cellular rejection (ACR) and the development of cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). Substudy of the SCHEDULE trial (n = 115), where de novo HTx recipients were randomized to (i) everolimus with early CNI elimination or (ii) CNI-based immunosuppression. Seventy-six patients (66%) were included based on matched intravascular ultrasound (IVUS) examinations at baseline and year 3 post-HTx. Biopsy-proven ACR within year 1 post-HTx was recorded and graded (1R, 2R, 3R). Development of CAV was assessed by IVUS and coronary angiography at year 3 post-HTx. Median age was 53 years (45-61), and 71% were male. ACR was recorded in 67%, and patients were grouped by rejection profile: no ACR (33%), only 1R (42%), and ≥2R (25%). Median ∆MIT (maximal intimal thickness) was not significantly different between groups (P = 0.84). The incidence of CAV was 49% by IVUS and 26% by coronary angiography with no significant differences between groups. No correlation was found between number of 1R and ∆MIT (r = -0.025, P = 0.83). The number of 1R was not a significant predictor of ∆MIT (P = 0.58), and no significant interaction with treatment was found (P = 0.98). The burden of mild ACR was not associated with CAV development.
Authors: Nelson Laerke Marie , Andreassen Arne Kristian , Arora Satish , Andersson Bert , Gude Einar , Eiskjaer Hans , Rådegran Göran , Dellgren Göran , Gullestad Lars , Gustafsson Finn ,

Reference:

  1. ncbi.nlm.nih.gov. [Last access 2020/01/20].

Related products :

Catalog number Product name Quantity
37-057-232181 Coronary Artery Atherosclerosis Heart 5 Slides
37-057-230237 Coronary Artery Atherosclerosis Heart 1 mg
C1236122Hd-5 cDNA _ Coronary Artery Atherosclerosis Heart 40 rxn
KMA0888 The model of coronary bypass of heart, 3 parts Set
NB820-59306 Coronary Artery Atherosclerosis Heart 1 mg